BRTX - Company ID 0001505497
The table below shows BioRestorative Therapies, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.51M | $547.89K | $884.38K | $1.68M | - | - |
| Short-term investments | $1.44M | $10.18M | $10.18M | $13.07M | - | - |
| Receivables | $15.50K | $188.40K | $19.30K | $16.00K | $5.00K | $17.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $3.14M |
| $11.14M |
| $11.39M |
| $15.13M |
| $21.47M |
| $3.19M |
| Property, plant & equipment | $358.77K | $362.94K | $356.06K | $261.00K | $37.99K | $21.91K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $4.08M | $12.28M | $12.61M | $16.43M | $22.45M | $4.35M |
| Accounts payable | $1.34M | $483.07K | $189.39K | $170.90K | $50.83K | $118.85K |
| Total current liabilities | $3.72M | $3.75M | $2.61M | $440.30K | $363.82K | $1.04M |
| Long-term debt | - | - | - | - | $250.00K | - |
| Total liabilities | - | $3.75M | $2.61M | $602.62K | $856.50K | $5.68M |
| Retained earnings | -$169.92M | -$155.68M | -$167.06M | -$152.64M | -$134.15M | -$89.84M |
| Total equity | $356.74K | $8.53M | $10.00M | $15.83M | $21.60M | -$1.33M |